arrow_back Back to App

Streamlining Research on Controlled Substances Act

This act aims to simplify rules for scientific research on controlled substances, potentially accelerating the development of new medicines and therapies. The changes primarily affect researchers and institutions, making it easier to obtain permits and conduct studies, which could indirectly benefit citizens' health.
Key points
Simplifying registration procedures for researchers conducting studies on controlled substances.
Allowing research at multiple sites on a single campus under one registration.
Eliminating the need for new inspections when expanding research to similar substances.
Facilitating the continuation of research on substances newly added to the controlled list.
Permitting the processing of small quantities of controlled substances for research without additional manufacturing permits.
Mandating a review and issuance of guidelines to further streamline the research process.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2405
Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
Process start date: 2021-04-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Streamlining Research on Controlled Substances Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2405.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-04-08.

What are the main provisions?

Key points include:

  • Simplifying registration procedures for researchers conducting studies on controlled substances.
  • Allowing research at multiple sites on a single campus under one registration.
  • Eliminating the need for new inspections when expanding research to similar substances.
  • Facilitating the continuation of research on substances newly added to the controlled list.
  • Permitting the processing of small quantities of controlled substances for research without additional manufacturing permits.
  • Mandating a review and issuance of guidelines to further streamline the research process.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Griffith, H. Morgan [R-VA-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Courts and Law